CIP2A and colorectal carcinoma: The concentrations of CIP2A had significantly increased in the sera of patients with CRC, compared to normal individuals (9.140 ± 0.937 vs. 1.659 ± 0.375 ng/mL, respectively; P = 0.000; Fig. 5a).